Switzerland · Who invested in ImmunOS?
ImmunOS's investors include Pfizer, BioMedPartners, Redalpine, Schroder Adveq and BERNINA BioInvest, and 1 more on record. Pfizer led its latest round.
Switzerland · Series A startup
Who invested in ImmunOS
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2019, from 1 source
- Latest round
- Series A, $15MDec 2019
- Led by
- Pfizer and BioMedPartners
- Investors
- 6 (2 led)
The rounds
- Dec 2019Series A$15M
PfizerLead
BioMedPartnersLead
Redalpine- Schroder Adveq
- BERNINA BioInvest
- Wille Finance AG
Reported by FinSMEs
Everyone who backed them
Schroder AdveqVC firm1round
BERNINA BioInvestno record of our own yet1round
Wille Finance AGno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ImmunOS
How much has ImmunOS raised?
ImmunOS has raised $15M across 1 round since 2019.
When did ImmunOS last raise?
ImmunOS's most recent round was a Series A of $15M in Dec 2019, led by Pfizer.
What was ImmunOS's biggest round?
Its most recent round, $15M in Dec 2019, is also its largest on record.
Who backed ImmunOS first?
ImmunOS's first round on record, in Dec 2019, was backed by Pfizer, BioMedPartners and Redalpine and 3 others.
What stage is ImmunOS at?
ImmunOS's latest named round is a Series A, in Dec 2019.
Where is ImmunOS based?
ImmunOS is based in Switzerland.
Who led ImmunOS's rounds?
Pfizer led the Series A in 2019.
Companies like ImmunOS
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.